POLLARD BLOODSTOCK LIMITED

Company Registration Number:
SC809415 (Scotland)

Unaudited abridged accounts for the year ended 31 May 2025

Period of accounts

Start date: 03 May 2024

End date: 31 May 2025

POLLARD BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2025

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

POLLARD BLOODSTOCK LIMITED

Company Information

for the Period Ended 31 May 2025




Director: ANDREW POLLARD
Registered office: 13/5 Whistlefield Court
2 Canniesburn Road
Bearsden
Glasgow
GB-SCT
G61 1PX
Company Registration Number: SC809415 (Scotland)

POLLARD BLOODSTOCK LIMITED

Balance sheet

As at 31 May 2025


Notes
13 months to
31 May 2025
£
Fixed assets
Tangible assets: 4 13,000
Total fixed assets: 13,000
Current assets
Debtors: 861
Cash at bank and in hand: 1,149
Total current assets: 2,010
Creditors: amounts falling due within one year: ( 33,880 )
Net current assets (liabilities): ( 31,870 )
Total assets less current liabilities: ( 18,870 )
Total net assets (liabilities): ( 18,870 )

The notes form part of these financial statements

POLLARD BLOODSTOCK LIMITED

Balance sheet continued

As at 31 May 2025


Notes
13 months to
31 May 2025
£
Capital and reserves
Called up share capital: 1
Profit and loss account: ( 18,871 )
Shareholders funds: ( 18,870 )

For the year ending 31 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 10 September 2025
And Signed On Behalf Of The Board By:

Name: ANDREW POLLARD
Status: Director

The notes form part of these financial statements

POLLARD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

POLLARD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2025

  • 2. Employees

    13 months to
    31 May 2025
    Average number of employees during the period 0

POLLARD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2025

  • 3. Off balance sheet disclosure

    No

POLLARD BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2025

4. Tangible Assets

Total
Cost £
Additions 13,000
Disposals -
Revaluations -
Transfers -
At 31 May 2025 13,000
Depreciation
Charge for year 0
On disposals -
Other adjustments -
At 31 May 2025 0
Net book value
At 31 May 2025 13,000